The pharmacokinetic profile from the therapeutic dose range in humans needs to be identified, as reports with rodents indicate that bigger doses result in non-linear PK profile, and subjective effects at higher doses might count on the CYP2D6 genotype.A escalating human body of research is demonstrating the efficacy of copyright medications includi